These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3776 related articles for article (PubMed ID: 32367170)

  • 1. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
    Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F;
    Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-dimer and mortality in COVID-19: a self-fulfilling prophecy or a pathophysiological clue?
    Breakey N; Escher R
    Swiss Med Wkly; 2020 May; 150():w20293. PubMed ID: 32459857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary embolism or thrombosis in ARDS COVID-19 patients: A French monocenter retrospective study.
    Contou D; Pajot O; Cally R; Logre E; Fraissé M; Mentec H; Plantefève G
    PLoS One; 2020; 15(8):e0238413. PubMed ID: 32853267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients With COVID-19.
    Berger JS; Kunichoff D; Adhikari S; Ahuja T; Amoroso N; Aphinyanaphongs Y; Cao M; Goldenberg R; Hindenburg A; Horowitz J; Parnia S; Petrilli C; Reynolds H; Simon E; Slater J; Yaghi S; Yuriditsky E; Hochman J; Horwitz LI
    Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2539-2547. PubMed ID: 32840379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulopathy in COVID-19: Manifestations and management.
    Mucha SR; Dugar S; McCrae K; Joseph D; Bartholomew J; Sacha GL; Militello M
    Cleve Clin J Med; 2020 Jul; 87(8):461-468. PubMed ID: 32409435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19-Associated Coagulopathy and Inflammatory Response: What Do We Know Already and What Are the Knowledge Gaps?
    Görlinger K; Dirkmann D; Gandhi A; Simioni P
    Anesth Analg; 2020 Nov; 131(5):1324-1333. PubMed ID: 33079850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
    Miesbach W; Makris M
    Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulopathy in COVID-19: Focus on vascular thrombotic events.
    Shi W; Lv J; Lin L
    J Mol Cell Cardiol; 2020 Sep; 146():32-40. PubMed ID: 32681845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous Thromboembolism Events Following Venovenous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Syndrome Coronavirus 2 Based on CT Scans.
    Parzy G; Daviet F; Puech B; Sylvestre A; Guervilly C; Porto A; Hraiech S; Chaumoitre K; Papazian L; Forel JM
    Crit Care Med; 2020 Oct; 48(10):e971-e975. PubMed ID: 32618700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients.
    Zhang Y; Cao W; Jiang W; Xiao M; Li Y; Tang N; Liu Z; Yan X; Zhao Y; Li T; Zhu T
    J Thromb Thrombolysis; 2020 Oct; 50(3):580-586. PubMed ID: 32648093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study.
    Ferrando C; Mellado-Artigas R; Gea A; Arruti E; Aldecoa C; Bordell A; Adalia R; Zattera L; Ramasco F; Monedero P; Maseda E; Martínez A; Tamayo G; Mercadal J; Muñoz G; Jacas A; Ángeles G; Castro P; Hernández-Tejero M; Fernandez J; Gómez-Rojo M; Candela Á; Ripollés J; Nieto A; Bassas E; Deiros C; Margarit A; Redondo FJ; Martín A; García N; Casas P; Morcillo C; Hernández-Sanz ML;
    Rev Esp Anestesiol Reanim (Engl Ed); 2020 Oct; 67(8):425-437. PubMed ID: 32800622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empiric Therapeutic Anticoagulation and Mortality in Critically Ill Patients With Respiratory Failure From SARS-CoV-2: A Retrospective Cohort Study.
    Ferguson J; Volk S; Vondracek T; Flanigan J; Chernaik A
    J Clin Pharmacol; 2020 Nov; 60(11):1411-1415. PubMed ID: 32885463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The coagulopathy, endotheliopathy, and vasculitis of COVID-19.
    Iba T; Connors JM; Levy JH
    Inflamm Res; 2020 Dec; 69(12):1181-1189. PubMed ID: 32918567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral Coagulopathy in Patients With COVID-19: Treatment and Care.
    Kipshidze N; Dangas G; White CJ; Kipshidze N; Siddiqui F; Lattimer CR; Carter CA; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029620936776. PubMed ID: 32687449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2.
    Beun R; Kusadasi N; Sikma M; Westerink J; Huisman A
    Int J Lab Hematol; 2020 Jun; 42 Suppl 1(Suppl 1):19-20. PubMed ID: 32311843
    [No Abstract]   [Full Text] [Related]  

  • 16. Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes.
    Grobler C; Maphumulo SC; Grobbelaar LM; Bredenkamp JC; Laubscher GJ; Lourens PJ; Steenkamp J; Kell DB; Pretorius E
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far?
    Tal S; Spectre G; Kornowski R; Perl L
    Acta Haematol; 2020; 143(5):417-424. PubMed ID: 32396903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 and thrombosis: Beyond a casual association.
    López Castro J
    Med Clin (Barc); 2020 Jul; 155(1):44. PubMed ID: 32446683
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.
    Al-Samkari H; Karp Leaf RS; Dzik WH; Carlson JCT; Fogerty AE; Waheed A; Goodarzi K; Bendapudi PK; Bornikova L; Gupta S; Leaf DE; Kuter DJ; Rosovsky RP
    Blood; 2020 Jul; 136(4):489-500. PubMed ID: 32492712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19: progression of disease and intravascular coagulation - present status and future perspectives.
    Harenberg J; Favaloro E
    Clin Chem Lab Med; 2020 Jun; 58(7):1029-1036. PubMed ID: 32406381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 189.